Johnson & Johnson Debt-to-EBITDA Ratio Growth & History (JNJ)
Johnson & Johnson's debt-to-ebitda ratio was 1.20 for fiscal 2025.
View full Johnson & Johnson company overviewJohnson & Johnson annual debt-to-ebitda ratio history
| Fiscal year | Period ended | Debt-to-EBITDA ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-28 | 1.20 | −0.33 | −21.32% |
| 2024 | 2024-12-29 | 1.53 | 0.22 | +16.86% |
| 2023 | 2023-12-31 | 1.31 | −0.23 | −15.15% |
| 2022 | 2023-01-01 | 1.54 | — | — |
| 2014 | 2014-12-28 | 0.73 | −0.15 | −17.32% |
| 2013 | 2013-12-29 | 0.89 | 0.02 | +2.19% |
| 2012 | 2012-12-30 | 0.87 | −0.29 | −25.20% |
| 2011 | 2012-01-01 | 1.16 | 0.35 | +43.16% |
| 2010 | 2011-01-02 | 0.81 | 0.06 | +7.82% |
| 2009 | 2010-01-03 | 0.75 | — | — |
Johnson & Johnson quarterly debt-to-ebitda ratio
| Fiscal quarter | Period ended | Debt-to-EBITDA ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-28 | 1.44 | — | — |
| Q1 2026 | 2026-03-29 | 1.63 | — | — |
| Q1 2015 | 2015-03-29 | 0.74 | −0.06 | −6.90% |
| Q4 2014 | 2014-12-28 | 0.73 | −0.15 | −17.32% |
| Q3 2014 | 2014-09-28 | 0.60 | −0.13 | −18.14% |
| Q2 2014 | 2014-06-29 | 0.76 | 0.04 | +5.43% |
| Q1 2014 | 2014-03-30 | 0.80 | −0.07 | −8.40% |
| Q4 2013 | 2013-12-29 | 0.89 | 0.02 | +2.19% |
| Q3 2013 | 2013-09-29 | 0.73 | −0.33 | −31.16% |
| Q2 2013 | 2013-06-30 | 0.72 | −0.34 | −31.97% |
| Q1 2013 | 2013-03-31 | 0.87 | −0.25 | −22.28% |
| Q4 2012 | 2012-12-30 | 0.87 | −0.29 | −25.20% |
| Q3 2012 | 2012-09-30 | 1.06 | — | — |
| Q2 2012 | 2012-07-01 | 1.06 | — | — |
| Q1 2012 | 2012-04-01 | 1.12 | — | — |
| Q4 2011 | 2012-01-01 | 1.16 | — | — |
Johnson & Johnson debt-to-ebitda ratio trends
Between the periods ended 2010-01-03 and 2025-12-28, Johnson & Johnson's debt-to-ebitda ratio increased from 0.75 to 1.20, a change of 0.45. The latest reported quarter, Q2 2026, shows 1.44.
What the debt-to-EBITDA ratio means
Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.
How debt-to-EBITDA is calculated
TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Johnson & Johnson source filings ↗Community posts
Apollo reportedly nears $20 billion talks for J&J orthopedics business
Apollo ($APO) is in talks to acquire Johnson & Johnson’s ($JNJ) DePuy Synthes orthopedics business in a transaction that could be worth around $20 billion, Reuters reported, citing Bloomberg. The unit generated approximately $9.3 billion in ...